Impact of Clinical Pharmacist Interventions in Management of Diabetes in Primary Care in Saudi Arabia

2021 ◽  
Vol 12 (4) ◽  
pp. 2582-2594
Author(s):  
Maha Aldraimly ◽  
Syed Azhar Bin Syed Sulaiman ◽  
Ahmed Ibrahim Nouri ◽  
Salma Fahad Alanazi ◽  
Reem Fahad Alanazi ◽  
...  

The study aimed to identify the impact and effectiveness of clinical pharmacist intervention on the management and overall quality of life of diabetic patients. Two cross-sectional studies using SF36 Health Survey, involving physicians and pharmacists at the Ambulatory Care Department in Riyadh, Saudi Arabia. Diabetic patients showed significant improvements in their QoL in terms of general health, energy and fatigue, pain scores, and social, emotional, and physical functions. Moreover, PC was found to have a significant impact on diabetes related QoL along with various outcome indicators, such as HbA1c, random blood sugar, and lipid profile in such patients. Additionally, satisfactory knowledge, good practice in identifying prescription errors were found among pharmacists. This study reveals that clinical pharmacists are valuable members of interdisciplinary primary care teams in ambulatory care. This can positively impact glycemic control in patients with type 2 diabetes and improve their quality of life. Also, the current study presented that a satisfactory extent of pharmaceutical care by an ambulatory clinical pharmacist was effective in improving HbA1c in patients with diabetes. A clinical pharmacist in ambulatory care was found to be eminent and of an added value to the patients, physicians, and healthcare team.

Author(s):  
Khaled Alghamdi ◽  
Feras Aljohani ◽  
Ala Alrehaili ◽  
Ahmed Alhusayni ◽  
Turki Alrehaili ◽  
...  

2020 ◽  
Vol 17 (34) ◽  
pp. 867-873
Author(s):  
Dhfer ALSHAYBAN ◽  
Royes JOSEPH

Diabetes is a common chronic disease that is considered as one of the fastest-growing health problems in the world. Adherence to medications could be an important factor in reducing these complications and improving the quality of life. The purpose of this research was to assess the impact of treatment adherence on health-related quality of life in patients with type 2 diabetes. A multicenter cross-sectional study was carried out among 368 diabetes patients. General Medication Adherence Scale was used to assess the adherence level and EuroQol-5D to assess the quality of life. The results show that 19%, 21%, and 23% of patients had maintained low medication adherence due to patient’s intentional or unintentional behavior due to additional diseases or pills burden and due to financial constraints, respectively. Overall, 43% (n=162) participants had maintained high medication adherence, and 37% (n=138) had maintained low medication adherence to antidiabetic drugs. Nearly one-third (31%) of patients with high overall adherence had perfect health state in comparison with 4% among patients with low adherence. Further, the lower proportion (21%) of patients with high overall adherence had perfect health state in comparison with that among patients with low adherence (34%). In addition to the overall adherence, the association was statistically significant for the domains related to non-adherence due to the patient’s intentional or unintentional behavior (p-value 0.001) and non-adherence due to additional diseases or pills burden (p-value 0.001) after taking into account of socio-demographic and clinical characteristics. In conclusion, the findings suggest that the policymakers should establish an intervention to improve adherence to diabetic treatment, and thus improve the quality of life for the type 2 diabetic patients.


Pharmacy ◽  
2020 ◽  
Vol 8 (3) ◽  
pp. 113
Author(s):  
Mo Chen ◽  
Tejal Patel ◽  
Feng Chang

Background: Chronic pain is a prevalent condition, experienced by 15.3% to 55% of Canadians, that is difficult to manage. With their broad accessibility and expertise on drugs, primary care pharmacists can help patients optimize their pain management. Methods: The objective of this study is to examine the effectiveness of a primary care, pharmacist-driven chronic pain intervention on pain and quality of life in patients with chronic non-cancer pain. A three-month naturalistic prospective study was conducted in primary care settings (five community pharmacies and one Family Health Team) across Ontario, Canada with a total of six pharmacists and 19 study participants. The primary care, pharmacist-driven chronic pain intervention consisted of patient assessments, medication reviews, care plan recommendations, and patient education. In order to evaluate the effectiveness of the intervention, pain intensity, pain interference, and quality of life were evaluated at baseline and at follow up (week 2 and month 3). Results: Trends towards improvement in pain and quality of life were found, however, these improvements were not statistically significant at follow up (month 3). Conclusions: This study provides the foundational research required to better understand the impact of Ontario pharmacists’ extended role in pain management in non-cancer patients within multiple primary care settings (e.g., Family Health Team, etc.) and has illustrated the importance of modifying and customizing care plans in patients with chronic pain. A larger sample size with tailored outcome measures may be necessary to better highlight significant improvements in pain and quality of life in patients with chronic non-cancer pain using a primary care, pharmacist-driven intervention.


2020 ◽  
Vol 28 (12) ◽  
pp. 1514-1519
Author(s):  
Diena M. Almasri ◽  
Ahmad O. Noor ◽  
Ragia H. Ghoneim ◽  
Alaa A. Bagalagel ◽  
Mansour Almetwazi ◽  
...  

2013 ◽  
Vol 83 (6) ◽  
pp. 1043-1048 ◽  
Author(s):  
Irfan Dawoodbhoy ◽  
Elsa K. Delgado-Angulo ◽  
Eduardo Bernabé

ABSTRACT Objective: To assess the relationship between malocclusion severity and quality of life in children. Materials and Method: Two hundred and seventy-eight children aged 11 to 14 years were recruited voluntarily from the Dental and Maxillofacial Centre of the Almana General Hospital in Alkhobar, Saudi Arabia. The children were asked to fill out the Arabic version of the Child Perception Questionnaire for 11- to 14-year-old children (CPQ11–14) and were then clinically examined to determine the severity of their malocclusion using the Dental Aesthetic Index (DAI). Multivariate analysis of variance was used to compare the four domains and the total CPQ11–14 scores between the four DAI severity groups. Results: Significant differences were found between DAI severity groups for the four domains and the total CPQ11–14 scores. Although children with very severe (handicapping) malocclusion had significantly higher domain and total CPQ11–14 scores than all the other groups (differences of up to 6 and 22 units, respectively, compared to children with no/minor malocclusion), there were no differences between those with no/minor, definite, and severe malocclusion. Conclusion: These findings suggest that only very severe malocclusion had an impact on the quality of life of the participants. Orthodontists should focus not only on clinical measures of malocclusion but should also consider the impact of severe malocclusion on patients' quality of life.


2014 ◽  
Vol 10 (5) ◽  
pp. e10
Author(s):  
Ibrahim ALAboudi ◽  
Mohammed Azmi Hassali ◽  
AsrulAkmal Shafie ◽  
Khalid AlRubeaan ◽  
Asim Hassan

2008 ◽  
Vol 16 (4) ◽  
pp. 264-274 ◽  
Author(s):  
Chiung-Yu Huang ◽  
Shoa-Jen Perng ◽  
Hisu-Fung Chen ◽  
Chien-Yu Lai

Sign in / Sign up

Export Citation Format

Share Document